Emmessar Biotech & Nutrition Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 3.65 million compared to INR 69.91 million a year ago. Revenue was INR 22.84 million compared to INR 84.56 million a year ago.

Net income was INR 4.75 million compared to INR 14.5 million a year ago. Basic earnings per share from continuing operations was INR 0.94. Diluted earnings per share from continuing operations was INR 0.94.